Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study

References

• Noubiap JJ, Temgoua MN, Tankeu R, Tochie JN, Wonkam A, Bigna JJ. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thromb J. 2018;16:27. doi:10.1186/s12959-018-0179-z.
   PubMed Web of Science ®Google Scholar
• Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017;178(2):319–326. doi:10.1111/bjh.14655.
   PubMed Web of Science ®Google Scholar
• Kumar R, Stanek J, Creary S, Dunn A, O'Brien SH. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study. Blood Adv. 2018;2(3):285–291. doi:10.1182/bloodadvances.2017012336.
   PubMed Web of Science ®Google Scholar
• Maserejian N, Hayflinger C, Eaton S, Madigan C, Hobbs WE. Central venous access device (CVAD) use and complications in sickle cell disease patients from medicaid and commercially-insured U.S. populations. Blood. 2015;126(23):2057–2057. doi:10.1182/blood.V126.23.2057.2057.
   Web of Science ®Google Scholar
• Carpenter SL, Richardson T, Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv. 2018;2(12):1403–1408. doi:10.1182/bloodadvances.2017013292.
   PubMed Web of Science ®Google Scholar
• Agha BS, Sturm JJ, Simon HK, Hirsh DA. Pulmonary embolism in the pediatric emergency department. Pediatrics. 2013;132(4):663–667. doi:10.1542/peds.2013-0126.
   PubMed Web of Science ®Google Scholar
• Hennelly KE, Baskin MN, Monuteuax MC, et al. Detection of pulmonary embolism in high-risk children. J Pediatr. 2016;178:214–218.e3. doi:10.1016/j.jpeds.2016.07.046.
   PubMed Web of Science ®Google Scholar
• Mornand P, Chalard F, Romain AS, et al. Bilateral pulmonary embolism mimicking acute chest syndrome in an adolescent with sickle cell disease. Arch Pediatr. 2017;24(7):625–629. doi:10.1016/j.arcped.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Burnham JM, Broussard M, Milbrandt T. Bilateral pulmonary embolism in an adolescent with sickle cell disease and a recent total hip arthroplasty: a case report and review of the literature. Iowa Orthop J. 2014;34:107–110.
   PubMedGoogle Scholar
• Villanueva H, Kuril S, Krajewski J, Sedrak A. Pulmonary thromboembolism in a child with sickle cell hemoglobin d disease in the setting of acute chest syndrome. Case Rep Pediatr. 2013;2013:875683. doi:10.1155/2013/875683.
   PubMedGoogle Scholar
• Sanfilippo KM, Wang TF, Gage BF, Liu W, Carson KR. Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data. Thromb Res. 2015;135(4):616–620. doi:10.1016/j.thromres.2015.01.012.
   PubMed Web of Science ®Google Scholar
• Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. The validity of ICD codes coupled with imaging procedure codes for identifying acute venous thromboembolism using administrative data. Vasc Med. 2015;20(4):364–368. doi:10.1177/1358863X15573839.
   PubMed Web of Science ®Google Scholar
• Badaki-Makun O, Casella JF, Tackett S, Tao X, Chamberlain JM. Association of antibiotic choice with hospital length of stay and risk factors for readmission in patients with sickle cell disease and acute chest syndrome: an observational cohort study. Ann Emerg Med. 2020;76(3S):S37–S45. doi:10.1016/j.annemergmed.2020.08.011.
   PubMedGoogle Scholar
• Creary SE, Krishnamurti L. Prodromal illness before acute chest syndrome in pediatric patients with sickle cell disease. J Pediatr Hematol Oncol. 2014;36(6):480–483. doi:10.1097/MPH.0000000000000146.
   PubMed Web of Science ®Google Scholar
• Rajpurkar M, Huang YV, Raffini L. Additional analysis of pediatric pulmonary embolism using the Pediatric Health Information System database. Blood Adv. 2019;3(17):2604–2607. doi:10.1182/bloodadvances.2019000071.
   PubMed Web of Science ®Google Scholar
• Biss TT, Brandão LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008;142(5):808–818. doi:10.1111/j.1365-2141.2008.07243.x.
   PubMed Web of Science ®Google Scholar
• Woods GM, Sharma R, Creary S, et al. Venous thromboembolism in children with sickle cell disease: a retrospective cohort study. J Pediatr. 2018;197:186–190.e1. doi:10.1016/j.jpeds.2018.01.073.
   PubMed Web of Science ®Google Scholar
• Mekontso Dessap A, Deux JF, Abidi N, et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2011;184(9):1022–1029. doi:10.1164/rccm.201105-0783OC.
   PubMed Web of Science ®Google Scholar
• Marongiu F, Mameli A, Grandone E, Barcellona D. Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? Semin Thromb Hemost. 2019;45(8):778–783. doi:10.1055/s-0039-1696942.
   PubMed Web of Science ®Google Scholar
• Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000;47(6):763–766. doi:10.1203/00006450-200006000-00013.
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost. 2011;37(3):226–236. doi:10.1055/s-0031-1273087.
   PubMed Web of Science ®Google Scholar
• Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med. 2006;119(10):897.e7-11–897.11. doi:10.1016/j.amjmed.2006.08.015.
   PubMed Web of Science ®Google Scholar
• Naik RP, Streiff MB, Haywood C, Jr, Segal JB, Lanzkron S. Venous thromboembolism incidence in the cooperative study of sickle cell disease. J Thromb Haemost. 2014;12(12):2010–2016. doi:10.1111/jth.12744.
   PubMed Web of Science ®Google Scholar
• Davis BA, Allard S, Qureshi A, British Society for Haematology, et al. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol. 2017;176(2):192–209. doi:10.1111/bjh.14383.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048. 2015;313:729. doi:10.1001/jama.2014.10517.
   PubMed Web of Science ®Google Scholar
• Sharma R, Woods GM, Creary S, et al. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019;66(4):e27588. doi:10.1002/pbc.27588.
   PubMed Web of Science ®Google Scholar
• Srisuwananukorn A, Raslan R, Zhang X, et al. Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease. Blood Adv. 2020;4(9):1978–1986. doi:10.1182/bloodadvances.2019001384.
   PubMed Web of Science ®Google Scholar
• Novelli EM, Huynh C, Gladwin MT, Moore CG, Ragni MV. Pulmonary embolism in sickle cell disease: a case-control study. J Thromb Haemost. 2012;10(5):760–766. doi:10.1111/j.1538-7836.2012.04697.x.
   PubMed Web of Science ®Google Scholar
• Yu TT, Nelson J, Streiff MB, Lanzkron S, Naik RP. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes. Thromb Res. 2016;141:35–38. doi:10.1016/j.thromres.2016.03.003.
   PubMed Web of Science ®Google Scholar
• Martin BJ, Chen G, Graham M, Quan H. Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res. 2014;14:70. doi:10.1186/1472-6963-14-70.
   PubMed Web of Science ®Google Scholar